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Galway Healthcare Professionals call on women to talk to their GP or 
practice nurse about Cervical Cancer Prevention 
 
 
Thursday, 29th November – Speaking at a public meeting at the Westwood 
Hotel, healthcare professionals encouraged women to get proactive and 
speak to their GP or practice nurse about their cervical health. Despite the 
fact that cervical cancer is now a largely preventable disease, a recent study 
showed that 31% of women in the Connaught/Ulster region (aged 25+) do not 
go for regular smear tests (at least one in the past 3 years).1 Although eight 
women died of the disease in this region last year,2 64% of local women 
(aged 25+) said that they did not consider themselves at risk of contracting 
cervical cancer.1  
 
Speaking at the meeting entitled “Cervical Cancer – Prevention For All 
Women”, Clinical Midwife Specialist, Maura Molloy said, “All women have to 
ensure they are taking responsibility for their cervical health and start asking 
questions about cervical cancer. Every woman should know and understand 
what causes this disease and even more importantly how it can now be 
prevented. Many women still don’t understand that cervical cancer is for 
example not hereditary and why they may be at risk. Getting vaccinated and 
continuing to have regular smear tests is the most effective way of preventing 
cervical cancer so I would strongly urge women to make the time to talk to 
their GP or practice nurse about how they can best protect themselves.” A 
local GP also spoke to women at the meeting as did Susie Kola, an NUI 
Galway PHD student.  
 
The meeting was supported by GlaxoSmithKline, who have been running an 
ongoing campaign to raise awareness about the disease and how it can be 
prevented by getting vaccinated as well as attending for regular smear tests at 
their local GP or health clinic.  
 
In Europe, a woman dies from cervical cancer every 18 minutes3, while 
approximately 70 - 75 women in Ireland die from the disease every year4. Any 
woman, young or old, who is sexually active, is at risk of cervical cancer5. The 
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disease is caused by certain high risk types of the Human Papilloma Virus 
(HPV) which up to 80% of women will come into contact with at some point in 
their life6,7,8. HPV is a common virus which is transmitted through sexual 
intercourse, or intimate skin-to-skin genital contact9.  
 
For more information log onto www.preventcervicalcancer.ie  
 
- Ends – 
 
For further information please contact: 
Claire Taaffe, Communications Manager, GSK. T : 01 4955218 / 086-
8053251. E : claire.l.taaffe@gsk.com 
 
 
Notes to Editors 
 
About GSK 
GlaxoSmithKline- one of the world’s leading research-based pharmaceutical 
and healthcare companies-is committed to improving the quality of human life 
by enabling people to do more, feel better and live longer.  
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